Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
TRxADE HEALTH, INC (TRXD)
|
Add to portfolio |
|
|
|
| Price: |
$2.59
| | Metrics |
| OS: |
1.25
|
M
| |
|
|
| Market cap: |
$3.23
|
M
| |
|
|
|
Net cash:
|
$745.6
|
k
| |
$0.60
|
per share
|
|
EV:
|
$2.48
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($1.4)
|
M
| |
|
|
|
EBIT
|
($1.4)
|
M
| |
|
|
| EPS |
($3.03)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 11.4 | 9.9 | 17.1 | 7.4 | 3.8 | 2.9 | 6.0 | 2.9 |
| Revenue growth | 15.8% | -42.2% | 130.3% | 94.1% | 30.7% | -50.9% | 105.0% | 94.7% |
| Cost of goods sold | 6.0 | 5.1 | 11.4 | 2.6 | 0.4 | 0.0 | 3.5 | 0.2 |
| Gross profit | 5.5 | 4.7 | 5.7 | 4.9 | 3.4 | 2.9 | 2.5 | 2.7 |
| Gross margin | 47.6% | 48.0% | 33.3% | 65.5% | 88.3% | 100.0% | 41.6% | 93.5% |
| Selling, general and administrative | | | | | | | | |
| General and administrative | 6.2 | 6.8 | 7.5 | 4.4 | 3.5 | 2.5 | 3.5 | 2.9 |
| EBITA | -2.8 | -4.6 | -1.8 | 0.1 | -0.1 | 0.4 | -1.0 | -0.1 |
| EBITA margin | -24.1% | -46.5% | -10.4% | 1.7% | -2.3% | 13.5% | -16.9% | -4.7% |
| Amortization of intangibles | 0.0 | | | | | | | |
| EBIT | -2.8 | -4.6 | -1.8 | 0.1 | -0.1 | 0.4 | -1.0 | -0.1 |
| EBIT margin | -24.5% | -46.5% | -10.4% | 1.7% | -2.3% | 13.5% | -16.9% | -4.7% |
| Pre-tax income | -3.9 | -5.3 | -2.5 | -0.3 | 0.0 | 0.3 | -1.2 | -0.3 |
| Income taxes | -0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.6 | 0.9 |
| Tax rate | 11.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | | |
| Earnings from continuing ops | -3.5 | -5.3 | -2.5 | -0.3 | 0.0 | 0.3 | -1.4 | -0.3 |
| Earnings from discontinued ops | | | | | | | 0.2 | -0.9 |
| Net income | -3.5 | -5.3 | -2.5 | -0.3 | 0.0 | 0.3 | -1.2 | -1.1 |
| Net margin | -30.3% | -53.8% | -14.8% | -3.8% | 0.2% | 9.9% | -19.6% | -38.4% |
| |
| Diluted EPS | ($0.41) | ($0.65) | ($0.33) | ($0.05) | $0.00 | $0.01 | ($0.04) | ($0.01) |
| Shares outstanding (diluted) | 8.5 | 8.1 | 7.7 | 5.9 | 5.8 | 34.1 | 31.5 | 31.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|